Pregled bibliografske jedinice broj: 339245
F-18-FDG-PET in patients with lymphoma-long-term follow-up study
F-18-FDG-PET in patients with lymphoma-long-term follow-up study // Nuklearmedizin
Stuttgart: Schattauer, 2008. str. 129-129 (predavanje, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 339245 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
F-18-FDG-PET in patients with lymphoma-long-term follow-up study
Autori
Huić, Dražen ; Mutvar, Andrea ; Kinda-Bašić, Sanda ; Aurer, Igor ; Radman, Ivo ; Grošev, Darko ; Labar, Boris ; Žuvić, Marijan ; Dodig, Damir ; Nemet, Damir
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Nuklearmedizin
/ - Stuttgart : Schattauer, 2008, 129-129
Skup
Sixth international congress of the Croatian society of nuclear medicine
Mjesto i datum
Opatija, Hrvatska, 09.05.2008. - 12.05.2008
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
PET; limfomi; praćenje
(PET; lymphoma follow-up)
Sažetak
Aim: The purpose of this study was to asses the prognostic value of fluorine-18-fluorodeoxyglucose (FDG) - positron emission tomography (PET) in long-term follow-up of patients with Hodgkin’ s disease (HD) and non-Hodgkin lymphoma (NHL). Methods: This single centre study comprised 31 consecutive patients (median age 35 years ; range 16-66 years) with primary or recurrent biopsy confirmed lymphoma with a follow-up of at least 48 months (median 57 months ; range 48-75 months). PET studies were performed using hybrid PET camera with triple head coincidence imaging capability within 3 months after completion of therapy. The long-term follow-up data were extracted from the patients’ medical files. Results: Fifteen patients (5 NHL, 10 HD) had a negative PET scan. They did not receive any therapy after FDG-PET, none of them relapsed. Twelve patients presented with clear FDG pathological accumulation in one or more sites previously shown to be involved by lymphoma. Ten patients received further therapy. Six of them never achieved complete remission. Three patients entered complete remission but relapsed despite of additional therapy. Two patients were noted as false - positive. In four patients only slightly increased FDG uptake was observed (equivocal findings). Conclusions: This methodology enables reliable prognosis in long-term follow-up of patients with HD and NHL. A negative PET scan can reassure patients and their doctors that disease is not active.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
108-1081872-2061 - LIMFOPROLIFERATIVNE BOLESTI I TRANSPLANTACIJA KRVOTVORNIH MATIČNIH STANICA (Nemet, Damir, MZOS ) ( CroRIS)
108-1081872-2062 - Uloga pozitronske emisijske tomografije (PET) u bolesnika sa zloćudnim tumorima (Huić, Dražen, MZOS ) ( CroRIS)
Ustanove:
Klinički bolnički centar Zagreb
Profili:
Boris Labar
(autor)
Damir Dodig
(autor)
Igor Aurer
(autor)
Damir Nemet
(autor)
Dražen Huić
(autor)
Ivo Radman-Livaja
(autor)
Darko Grošev
(autor)